1.The Immune System in Irritable Bowel Syndrome.
Giovanni BARBARA ; Cesare CREMON ; Giovanni CARINI ; Lara BELLACOSA ; Lisa ZECCHI ; Roberto DE GIORGIO ; Roberto CORINALDESI ; Vincenzo STANGHELLINI
Journal of Neurogastroenterology and Motility 2011;17(4):349-359
The potential relevance of systemic and gastrointestinal immune activation in the pathophysiology and symptom generation in the irritable bowel syndrome (IBS) is supported by a number of observations. Infectious gastroenteritis is the strongest risk factor for the development of IBS and increased rates of IBS-like symptoms have been detected in patients with inflammatory bowel disease in remission or in celiac disease patients on a gluten free diet. The number of T cells and mast cells in the small and large intestine of patients with IBS is increased in a large proportion of patients with IBS over healthy controls. Mediators released by immune cells and likely from other non-immune competent cells impact on the function of enteric and sensory afferent nerves as well as on epithelial tight junctions controlling mucosal barrier of recipient animals, isolated human gut tissues or cell culture systems. Antibodies against microbiota antigens (bacterial flagellin), and increased levels of cytokines have been detected systemically in the peripheral blood advocating the existence of abnormal host-microbial interactions and systemic immune responses. Nonetheless, there is wide overlap of data obtained in healthy controls; in addition, the subsets of patients showing immune activation have yet to be clearly identified. Gender, age, geographic differences, genetic predisposition, diet and differences in the intestinal microbiota likely play a role and further research has to be done to clarify their relevance as potential mechanisms in the described immune system dysregulation. Immune activation has stimulated interest for the potential identification of biomarkers useful for clinical and research purposes and the development of novel therapeutic approaches.
Abdominal Pain
;
Animals
;
Antibodies
;
Biomarkers
;
Celiac Disease
;
Cell Culture Techniques
;
Cytokines
;
Diet
;
Diet, Gluten-Free
;
Gastroenteritis
;
Genetic Predisposition to Disease
;
Humans
;
Immune System
;
Inflammatory Bowel Diseases
;
Intestine, Large
;
Irritable Bowel Syndrome
;
Mast Cells
;
Metagenome
;
Risk Factors
;
T-Lymphocytes
;
Tight Junctions
2.Impact of Preoperative Patient Characteristics and Flow Rate on Failure, Early Complications, and Voiding Dysfunction After a Transobturator Tape Procedure: A Multicentre Study.
Andrea COCCI ; Giovanni E CACCIAMANI ; Giorgio Ivan RUSSO ; Maria Angela CERRUTO ; Martina MILANESI ; Luis G MEDINA ; Sebastiano CIMINO ; Walter ARTIBANI ; Giuseppe MORGIA ; Marco CARINI ; Vincenzo LI MARZI
International Neurourology Journal 2017;21(4):282-288
PURPOSE: To evaluate the impact of preoperative patient characteristics and flow rate on failure, early postoperative complications, and voiding in patients who underwent transvaginal tension-free vaginal tape-obturator (TVT-O) treatment for uncomplicated stress urinary incontinence (SUI). METHODS: We retrospectively reviewed patients who underwent TVT-O for SUI at 3 Italian centres. The exclusion criteria were predominant voiding and storage symptoms suggestive of detrusor overactivity, the presence of grade >1 urogenital prolapse, previous pelvic radiotherapy or other clinical contraindications for surgical procedures, neurogenic bladder dysfunction, and collagen diseases. Multivariate logistic regression models were constructed to identify predictors of early voiding dysfunction after TVT-O. RESULTS: A total of 219 patients underwent TVT-O between January 2010 and December 2015. All patients received follow-up at 3, 6, and 12 months, and underwent a stress test, uroflowmetry, and bladder ultrasound to evaluate the postvoid residual volume. They also responded to the Urogenital Distress Inventory (UDI-6) questionnaire. The rates of persistent incontinence after TVT-O, postoperative complications, and satisfaction were 16.4% (36 of 219), 24.2% (53 of 219), and 86.3% (189 of 219), respectively. Nineteen patients (9.5%) experienced early voiding dysfunction. Based on an analysis of baseline characteristics, we determined that a cutoff value of 9.0 on the UDI-6 predicted postoperative SUI with 62% specificity, 72% sensitivity, and 66% accuracy. In the multivariate logistic regression analysis, a preoperative UDI-6≥9.0 was an independent predictor of postoperative SUI. The predictors of complications were menopause (P = 0.04) and the preoperative UDI-6 score (P = 0.01). CONCLUSIONS: Menopause and UDI-6 scores could be prognostic factors for persistent SUI after TVT-O. Well-designed prospective studies with a suitable number of patients are needed to corroborate our findings.
Collagen Diseases
;
Exercise Test
;
Female
;
Follow-Up Studies
;
Humans
;
Logistic Models
;
Menopause
;
Pelvic Organ Prolapse
;
Postoperative Complications
;
Prospective Studies
;
Radiotherapy
;
Residual Volume
;
Retrospective Studies
;
Sensitivity and Specificity
;
Suburethral Slings*
;
Ultrasonography
;
Urinary Bladder
;
Urinary Bladder, Neurogenic
;
Urinary Incontinence
;
Urinary Incontinence, Stress
;
Urodynamics